文献速递产科母胎医学

早产与足月子痫前期:母体及围产期并发症的相对负担

Preterm and term pre-eclampsia: Relative burdens of maternal and perinatal complications.
PubMed 文献 · BJOG · 2023-01-23

这项前瞻性观察性队列研究在两家英格兰产科单位纳入40241例单胎妊娠,其中早产子痫前期298例(0.7%,95%CI 0.66-0.83),足月子痫前期1194例(3.0%,95%CI 2.8-3.1)。早产子痫前期的母体及围产期不良事件风险更高,但足月子痫前期贡献了多数母体并发症和相当比例的围产期并发症。

要点

  • 早产子痫前期严重高血压18.5%,足月13.6%。
  • 早产子痫前期围产期死亡/严重新生儿病率29.5%,足月2.2%。
  • 足月子痫前期占严重高血压的74.7%。

核心结论

  • 早产子痫前期的不良事件风险高于足月子痫前期,但足月疾病与至少等效的母体不良事件总数及显著比例的围产期不良事件相关。
  • 应加大力度降低足月子痫前期的发生率。

研究设计与样本

  • 前瞻性观察性队列研究,在两家英格兰产科单位开展。
  • 纳入40241例单胎妊娠中发生子痫前期的未选择孕妇,子痫前期采用国际妊娠高血压研究学会定义。
  • 结局通过病历回顾确认,比较早产与足月子痫前期。

主要发现

  • 早产子痫前期298例(0.7%,95%CI 0.66-0.83),足月子痫前期1194例(3.0%,95%CI 2.8-3.1)。
  • 早产 vs 足月子痫前期:严重高血压18.5%(95%CI 14.5-23.3)vs 13.6%(95%CI 11.7-15.6)。
  • 早产 vs 足月子痫前期:母体死亡/严重母体病率7.4%(95%CI 4.9-10.9)vs 2.2%(95%CI 1.5-3.2)。
  • 早产 vs 足月子痫前期:围产期死亡/严重新生儿病率29.5%(95%CI 24.6-34.9)vs 2.2%(95%CI 1.5-3.2)。
  • 早产 vs 足月子痫前期:出生体重<第3百分位54.4%(95%CI 48.7-59.9)vs 14.2%(95%CI 12.4-16.3)。

关键数值与推荐

  • 足月子痫前期中严重高血压占全部子痫前期严重高血压的74.7%(95%CI 68.5-80.0)。
  • 足月子痫前期中母体死亡/严重母体病率占全部的54.2%(95%CI 40.3-67.4)。
  • 足月子痫前期中围产期死亡/严重新生儿病率占全部的22.8%(95%CI 16.1-31.3)。
  • 足月子痫前期中新生儿病房(NNU)入住≥48小时占全部的38.1%(95%CI 32.4-44.1)。
  • 足月子痫前期中出生体重<第3百分位占全部的51.2%(95%CI 45.8-56.5)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the relative burdens of maternal and perinatal complications for preterm and term pre-eclampsia. DESIGN: Prospective observational cohort study. SETTING: Two English maternity units. POPULATION: Unselected women with singleton pregnancies who developed pre-eclampsia (International Society for the Study of Hypertension in Pregnancy definition). METHODS: Outcomes were ascertained by health record review and compared between pregnancies with preterm (versus term) pre-eclampsia. MAIN OUTCOME MEASURES: Severe maternal hypertension, maternal mortality or major maternal morbidity, perinatal mortality or major neonatal morbidity, neonatal unit (NNU) admission ≥48 hours, and birthweight <3rd percentile. RESULTS: Among 40 241 singleton pregnancies, 298 (0.7%, 95% confidence interval [CI] 0.66-0.83) and 1194 (3.0%, 95% CI 2.8-3.1) developed preterm and term pre-eclampsia, respectively. Women with preterm (versus term) pre-eclampsia more commonly experienced adverse maternal or perinatal events: severe hypertension 18.5% (95% CI 14.5-23.3) versus 13.6% (95% CI 11.7-15.6); maternal mortality/major morbidity 7.4% (95% CI 4.9-10.9) versus 2.2% (95% CI 1.5-3.2); perinatal mortality/major neonatal morbidity 29.5% (95% CI 24.6-34.9) versus 2.2% (95% CI 1.5-3.2); and birthweight <3rd percentile 54.4% (95% CI 48.7-59.9) versus 14.2% (95% CI 12.4-16.3). However, in absolute terms, most maternal complications occurred in women with term pre-eclampsia, as did a large proportion of perinatal complications: severe hypertension 74.7% (95% CI 68.5-80.0); maternal mortality/major morbidity 54.2% (95% CI 40.3-67.4); perinatal mortality/major neonatal morbidity 22.8% (95% CI 16.1-31.3); NNU admission ≥48 hours 38.1% (95% CI 32.4-44.1); and birthweight <3rd percentile 51.2% (95% CI 45.8-56.5). CONCLUSIONS: Although adverse event risks are greater with preterm (versus term) pre-eclampsia, term disease is associated with at least equivalent total numbers of maternal, and a significant proportion of perinatal, adverse events. Increased efforts should be made to decrease the incidence of term pre-eclampsia.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. von Dadelszen P, Syngelaki A, Akolekar R, et al. Preterm and term pre-eclampsia: Relative burdens of maternal and perinatal complications. BJOG. 2023. PMID: 36562190. doi:10.1111/1471-0528.17370

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。